TY - JOUR AU - Jung, Y. AU - Lippard, S. J. PY - 2007 DA - 2007// TI - Direct cellular responses to platinum-induced DNA damage JO - Chem Rev VL - 107 UR - https://doi.org/10.1021/cr068207j DO - 10.1021/cr068207j ID - Jung2007 ER - TY - JOUR AU - Todd, R. C. AU - Lippard, S. J. PY - 2009 DA - 2009// TI - Inhibition of transcription by platinum antitumor compounds JO - Metallomics VL - 1 UR - https://doi.org/10.1039/b907567d DO - 10.1039/b907567d ID - Todd2009 ER - TY - JOUR AU - Baruah, H. AU - Barry, C. G. AU - Bierbach, U. PY - 2004 DA - 2004// TI - Platinum-intercalator conjugates: from DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation JO - Curr Top Med Chem VL - 4 UR - https://doi.org/10.2174/1568026043387313 DO - 10.2174/1568026043387313 ID - Baruah2004 ER - TY - JOUR AU - Kelland, L. PY - 2007 DA - 2007// TI - The resurgence of platinum-based cancer chemotherapy JO - Nat Rev Cancer VL - 7 UR - https://doi.org/10.1038/nrc2167 DO - 10.1038/nrc2167 ID - Kelland2007 ER - TY - JOUR AU - Betanzos-Lara, S. AU - Salassa, L. AU - Habtemariam, A. AU - Novakova, O. AU - Pizarro, A. M. AU - Clarkson, G. J. PY - 2012 DA - 2012// TI - Photoactivatable Organometallic Pyridyl Ruthenium(II) Arene Complexes JO - Organometallics VL - 31 UR - https://doi.org/10.1021/om201177y DO - 10.1021/om201177y ID - Betanzos-Lara2012 ER - TY - JOUR AU - Bugarcic, T. AU - Habtemariam, A. AU - Deeth, R. J. AU - Fabbiani, F. P. AU - Parsons, S. AU - Sadler, P. J. PY - 2009 DA - 2009// TI - Ruthenium(II) arene anticancer complexes with redox-active diamine ligands JO - Inorg Chem VL - 48 UR - https://doi.org/10.1021/ic9013366 DO - 10.1021/ic9013366 ID - Bugarcic2009 ER - TY - JOUR AU - Fernandez, R. AU - Melchart, M. AU - Habtemariam, A. AU - Parsons, S. AU - Sadler, P. J. PY - 2004 DA - 2004// TI - Use of chelating ligands to tune the reactive site of half-sandwich ruthenium(II)-arene anticancer complexes JO - Chemistry VL - 10 UR - https://doi.org/10.1002/chem.200400640 DO - 10.1002/chem.200400640 ID - Fernandez2004 ER - TY - JOUR AU - Habtemariam, A. AU - Melchart, M. AU - Fernandez, R. AU - Parsons, S. AU - Oswald, I. D. H. AU - Parkin, A. PY - 2006 DA - 2006// TI - Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N, N-, N, O-, and O,O-chelating ligands JO - J Med Chem VL - 49 UR - https://doi.org/10.1021/jm060596m DO - 10.1021/jm060596m ID - Habtemariam2006 ER - TY - JOUR AU - Ang, W. H. AU - Dyson, P. J. PY - 2006 DA - 2006// TI - Classical and non-classical ruthenium-based anticancer drugs: towards targeted chemotherapy JO - Eur J Inorg Chem VL - 20 UR - https://doi.org/10.1002/ejic.200600723 DO - 10.1002/ejic.200600723 ID - Ang2006 ER - TY - JOUR AU - Wang, F. Y. AU - Chen, H. M. AU - Parkinson, J. A. AU - Murdoch, P. D. AU - Sadler, P. J. PY - 2002 DA - 2002// TI - Reactions of a ruthenium(II) arene antitumor complex with cysteine and methionine JO - Inorg Chem VL - 41 UR - https://doi.org/10.1021/ic025538f DO - 10.1021/ic025538f ID - Wang2002 ER - TY - JOUR AU - Kuhn, P. S. AU - Pichler, V. AU - Roller, A. AU - Hejl, M. AU - Jakupec, M. A. AU - Kandioller, W. PY - 2015 DA - 2015// TI - Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential JO - Dalton Trans VL - 44 UR - https://doi.org/10.1039/C4DT01645A DO - 10.1039/C4DT01645A ID - Kuhn2015 ER - TY - JOUR AU - Leijen, S. AU - Burgers, S. A. AU - Baas, P. AU - Pluim, D. AU - Tibben, M. AU - Werkhoven, E. PY - 2015 DA - 2015// TI - Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy JO - Invest New Drugs VL - 33 UR - https://doi.org/10.1007/s10637-014-0179-1 DO - 10.1007/s10637-014-0179-1 ID - Leijen2015 ER - TY - JOUR AU - Lentz, F. AU - Drescher, A. AU - Lindauer, A. AU - Henke, M. AU - Hilger, R. A. AU - Hartinger, C. G. PY - 2009 DA - 2009// TI - Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study JO - Anticancer Drugs VL - 20 UR - https://doi.org/10.1097/CAD.0b013e328322fbc5 DO - 10.1097/CAD.0b013e328322fbc5 ID - Lentz2009 ER - TY - JOUR AU - Novakova, O. AU - Kasparkova, J. AU - Bursova, V. AU - Hofr, C. AU - Vojtiskova, M. AU - Chen, H. M. PY - 2005 DA - 2005// TI - Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity JO - Chem Biol VL - 12 UR - https://doi.org/10.1016/j.chembiol.2004.11.008 DO - 10.1016/j.chembiol.2004.11.008 ID - Novakova2005 ER - TY - JOUR AU - Ang, W. H. AU - Casini, A. AU - Sava, G. AU - Dyson, P. J. PY - 2011 DA - 2011// TI - Organometallic ruthenium-based antitumor compounds with novel modes of action JO - J Organomet Chem VL - 696 UR - https://doi.org/10.1016/j.jorganchem.2010.11.009 DO - 10.1016/j.jorganchem.2010.11.009 ID - Ang2011 ER - TY - JOUR AU - Bergamo, A. AU - Masi, A. AU - Peacock, A. F. A. AU - Habtemariam, A. AU - Sadler, P. J. AU - Sava, G. PY - 2010 DA - 2010// TI - In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model JO - J Inorg Biochem VL - 104 UR - https://doi.org/10.1016/j.jinorgbio.2009.10.005 DO - 10.1016/j.jinorgbio.2009.10.005 ID - Bergamo2010 ER - TY - JOUR AU - Weiss, A. AU - Bonvin, D. AU - Berndsen, R. H. AU - Scherrer, E. AU - Wong, T. J. AU - Dyson, P. J. PY - 2015 DA - 2015// TI - Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep08990 DO - 10.1038/srep08990 ID - Weiss2015 ER - TY - JOUR AU - Sebaugh, J. L. PY - 2011 DA - 2011// TI - Guidelines for accurate EC50/IC50 estimation JO - Pharm Stat VL - 10 UR - https://doi.org/10.1002/pst.426 DO - 10.1002/pst.426 ID - Sebaugh2011 ER - TY - JOUR AU - Morris, R. E. AU - Aird, R. E. AU - Murdoch Pdel, S. AU - Chen, H. AU - Cummings, J. AU - Hughes, N. D. PY - 2001 DA - 2001// TI - Inhibition of cancer cell growth by ruthenium(II) arene complexes JO - J Med Chem VL - 44 UR - https://doi.org/10.1021/jm010051m DO - 10.1021/jm010051m ID - Morris2001 ER - TY - JOUR AU - Chen, H. M. AU - Parkinson, J. A. AU - Parsons, S. AU - Coxall, R. A. AU - Gould, R. O. AU - Sadler, P. J. PY - 2002 DA - 2002// TI - Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts JO - J Am Chem Soc VL - 124 UR - https://doi.org/10.1021/ja017482e DO - 10.1021/ja017482e ID - Chen2002 ER - TY - JOUR AU - Chen, H. M. AU - Parkinson, J. A. AU - Morris, R. E. AU - Sadler, P. J. PY - 2003 DA - 2003// TI - Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms JO - J Am Chem Soc VL - 125 UR - https://doi.org/10.1021/ja027719m DO - 10.1021/ja027719m ID - Chen2003 ER - TY - JOUR AU - Andey, T. AU - Sudhakar, G. AU - Marepally, S. AU - Patel, A. AU - Banerjee, R. AU - Singh, M. PY - 2015 DA - 2015// TI - Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation JO - Mol Pharm VL - 12 UR - https://doi.org/10.1021/mp5008629 DO - 10.1021/mp5008629 ID - Andey2015 ER - TY - JOUR AU - Chandra-Kuntal, K. AU - Lee, J. AU - Singh, S. V. PY - 2013 DA - 2013// TI - Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic JO - Breast Cancer Res Treat VL - 138 UR - https://doi.org/10.1007/s10549-013-2440-2 DO - 10.1007/s10549-013-2440-2 ID - Chandra-Kuntal2013 ER - TY - JOUR AU - Singh, N. AU - Nigam, M. AU - Ranjan, V. AU - Sharma, R. AU - Balapure, A. K. AU - Rath, S. K. PY - 2009 DA - 2009// TI - Caspase mediated enhanced apoptotic action of cyclophosphamide- and resveratrol-treated MCF-7 cells JO - J Pharmacol Sci VL - 109 UR - https://doi.org/10.1254/jphs.08173FP DO - 10.1254/jphs.08173FP ID - Singh2009 ER - TY - JOUR AU - Guo, Z. J. AU - Sadler, P. J. PY - 2000 DA - 2000// TI - Medicinal inorganic chemistry JO - Adv Inorg Chem VL - 49 ID - Guo2000 ER - TY - JOUR AU - Verwilst, P. AU - Eliseeva, S. V. AU - Vander Elst, L. AU - Burtea, C. AU - Laurent, S. AU - Petoud, S. PY - 2012 DA - 2012// TI - A tripodal ruthenium-gadolinium metallostar as a potential alpha(v)beta(3) integrin specific bimodal imaging contrast agent JO - Inorg Chem VL - 51 UR - https://doi.org/10.1021/ic300717m DO - 10.1021/ic300717m ID - Verwilst2012 ER - TY - JOUR AU - Barry, N. P. E. AU - Sadler, P. J. PY - 2013 DA - 2013// TI - Exploration of the medical periodic table: towards new targets JO - Chem Commun VL - 49 UR - https://doi.org/10.1039/c3cc41143e DO - 10.1039/c3cc41143e ID - Barry2013 ER - TY - JOUR AU - Betanzos-Lara, S. AU - Novakova, O. AU - Deeth, R. J. AU - Pizarro, A. M. AU - Clarkson, G. J. AU - Liskova, B. PY - 2012 DA - 2012// TI - Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity JO - J Biol Inorg Chem VL - 17 UR - https://doi.org/10.1007/s00775-012-0917-9 DO - 10.1007/s00775-012-0917-9 ID - Betanzos-Lara2012 ER - TY - JOUR AU - Wang, F. Y. AU - Habtemariam, A. AU - Geer, E. P. L. AU - Fernandez, R. AU - Melchart, M. AU - Deeth, R. J. PY - 2005 DA - 2005// TI - Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity JO - Proc Natl Acad Sci USA VL - 102 UR - https://doi.org/10.1073/pnas.0505798102 DO - 10.1073/pnas.0505798102 ID - Wang2005 ER - TY - JOUR AU - Adhireksan, Z. AU - Davey, G. E. AU - Campomanes, P. AU - Groessl, M. AU - Clavel, C. M. AU - Yu, H. PY - 2014 DA - 2014// TI - Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity JO - Nature communications VL - 5 UR - https://doi.org/10.1038/ncomms4462 DO - 10.1038/ncomms4462 ID - Adhireksan2014 ER - TY - JOUR AU - Carvalho, I. AU - Milanezi, F. AU - Martins, A. AU - Reis, R. M. AU - Schmitt, F. PY - 2005 DA - 2005// TI - Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression JO - Breast Cancer Res VL - 7 UR - https://doi.org/10.1186/bcr1304 DO - 10.1186/bcr1304 ID - Carvalho2005 ER - TY - JOUR AU - Jong, J. S. AU - Diest, P. J. AU - Valk, P. AU - Baak, J. P. PY - 1998 DA - 1998// TI - Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: an inventory in search of autocrine and paracrine loops JO - J Pathol VL - 184 UR - https://doi.org/3.0.CO;2-H DO - 3.0.CO;2-H ID - Jong1998 ER - TY - JOUR AU - Linderholm, B. AU - Bergqvist, J. AU - Hellborg, H. AU - Johansson, U. AU - Linderholm, M. AU - Schoultz, E. PY - 2009 DA - 2009// TI - Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor JO - Med Oncol VL - 26 UR - https://doi.org/10.1007/s12032-008-9157-9 DO - 10.1007/s12032-008-9157-9 ID - Linderholm2009 ER - TY - JOUR AU - Mendoza-Villanueva, D. AU - Zeef, L. AU - Shore, P. PY - 2011 DA - 2011// TI - Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFbeta-dependent expression of the Wnt antagonist, sclerostin JO - Breast Cancer Res VL - 13 UR - https://doi.org/10.1186/bcr3048 DO - 10.1186/bcr3048 ID - Mendoza-Villanueva2011 ER - TY - JOUR AU - Vembar, S. S. AU - Brodsky, J. L. PY - 2008 DA - 2008// TI - One step at a time: endoplasmic reticulum-associated degradation JO - Nat Rev Mol Cell Biol VL - 9 UR - https://doi.org/10.1038/nrm2546 DO - 10.1038/nrm2546 ID - Vembar2008 ER - TY - JOUR AU - Bandi, N. AU - Kompella, U. B. PY - 2001 DA - 2001// TI - Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells JO - Eur J Pharmacol VL - 425 UR - https://doi.org/10.1016/S0014-2999(01)01192-X DO - 10.1016/S0014-2999(01)01192-X ID - Bandi2001 ER - TY - JOUR AU - Lecker, S. H. AU - Goldberg, A. L. AU - Mitch, W. E. PY - 2006 DA - 2006// TI - Protein degradation by the ubiquitin-proteasome pathway in normal and disease states JO - J Am Soc Nephrol VL - 17 UR - https://doi.org/10.1681/ASN.2006010083 DO - 10.1681/ASN.2006010083 ID - Lecker2006 ER - TY - JOUR AU - Taraboletti, G. AU - D’Ascenzo, S. AU - Giusti, I. AU - Marchetti, D. AU - Borsotti, P. AU - Millimaggi, D. PY - 2006 DA - 2006// TI - Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH JO - Neoplasia VL - 8 UR - https://doi.org/10.1593/neo.05583 DO - 10.1593/neo.05583 ID - Taraboletti2006 ER - TY - JOUR AU - Wang, G. J. AU - Randall, R. D. AU - Thayer, S. A. PY - 1994 DA - 1994// TI - Glutamate-induced intracellular acidification of cultured hippocampal neurons demonstrates altered energy metabolism resulting from Ca2+ loads JO - J Neurophysiol VL - 72 ID - Wang1994 ER - TY - JOUR AU - Bergamo, A. AU - Riedel, T. AU - Dyson, P. J. AU - Sava, G. PY - 2015 DA - 2015// TI - Preclinical combination therapy of the investigational drug NAMI-A(+) with doxorubicin for mammary cancer JO - Invest New Drugs VL - 33 UR - https://doi.org/10.1007/s10637-014-0175-5 DO - 10.1007/s10637-014-0175-5 ID - Bergamo2015 ER - TY - JOUR AU - Pavlidou, A. AU - Kroupis, C. AU - Dimas, K. PY - 2014 DA - 2014// TI - Association of survivin splice variants with prognosis and treatment of breast cancer JO - World J Clin Oncol VL - 5 UR - https://doi.org/10.5306/wjco.v5.i5.883 DO - 10.5306/wjco.v5.i5.883 ID - Pavlidou2014 ER - TY - JOUR AU - Pieper, R. O. AU - Futscher, B. W. AU - Erickson, L. C. PY - 1989 DA - 1989// TI - Transcription-terminating lesions induced by bifunctional alkylating agents in vitro JO - Carcinogenesis VL - 10 UR - https://doi.org/10.1093/carcin/10.7.1307 DO - 10.1093/carcin/10.7.1307 ID - Pieper1989 ER - TY - JOUR AU - Novakova, O. AU - Chen, H. M. AU - Vrana, O. AU - Rodger, A. AU - Sadler, P. J. AU - Brabec, V. PY - 2003 DA - 2003// TI - DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media JO - Biochemistry VL - 42 UR - https://doi.org/10.1021/bi034933u DO - 10.1021/bi034933u ID - Novakova2003 ER - TY - JOUR AU - Sevko, A. AU - Sade-Feldman, M. AU - Kanterman, J. AU - Michels, T. AU - Falk, C. S. AU - Umansky, L. PY - 2013 DA - 2013// TI - Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma JO - J Invest Dermatol VL - 133 UR - https://doi.org/10.1038/jid.2012.444 DO - 10.1038/jid.2012.444 ID - Sevko2013 ER - TY - JOUR AU - Dylla, S. J. AU - Beviglia, L. AU - Park, I. K. AU - Chartier, C. AU - Raval, J. AU - Ngan, L. PY - 2008 DA - 2008// TI - Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy JO - PLoS One VL - 3 UR - https://doi.org/10.1371/journal.pone.0002428 DO - 10.1371/journal.pone.0002428 ID - Dylla2008 ER -